Results 251 to 260 of about 462,118 (388)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Angiotensin converting enzyme 2 in patients with sepsis associate with comorbidities but neither with mortality nor with organ failure. [PDF]

Sci Rep
Forsberg F, Ruge T, Larsson A, Wändell P, Carlsson AC, Nilsson PM, Swärd P.   +6 more
europepmc   +1 more source

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. [PDF]

, 1988
Keiji Sakaguchi, Siew Yeen Chai, B. Jackson, C. I. Johnston, F. A. O. Mendelsohn   +4 more
openalex   +1 more source

Angiotensin Converting Enzyme 2: A Double-Edged Sword.

Circulation, 2020
Kaiming Wang, Mahmoud Gheblawi, G. Oudit
semanticscholar   +1 more source

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Transthoracic echocardiography (TTE) is recommended as a key investigation in patients with acute heart failure (AHF) in major guidelines. However, utilization and benefits are yet to be known in Thai patients. The study aims to evaluate the benefits of TTE and identify factors associated with the decision to perform TTE on patients with ...
Koravich Lorlowhakarn, Thanaporn Ratchataswan, Thiratest Leesutipornchai, Aunchalee Jaroenlapnopparat, Palapun Waitayangkoon, Supanee Sinphurmsukskul, Sarawut Siwamogsatham, Sarinya Puwanant, Smonporn Boonyaratavej Songmuang, Aekarach Ariyachaipanich   +9 more
wiley   +1 more source

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. [PDF]

, 1981
G. A. MacGregor, Nirmala D. Markandu, J Bayliss, J E Roulston, M. Squires, J.J. Morton   +5 more
openalex   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto, Yuki Matsuoka, Masahiro Seo, Takahisa Yamada, Daisaku Nakatani, Katsuki Okada, Akihiro Sunaga, Hirota Kida, Taiki Sato, Tetsuhisa Kitamura, Shunsuke Tamaki, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Yoshio Yasumura, Shungo Hikoso, Yohei Sotomi, Yasushi Sakata, on behalf of the OCVC‐Heart Failure Investigators   +19 more
wiley   +1 more source

Comparative Risk Assessment in Hypertensive Patients With Metabolic Syndrome by Exploring Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. [PDF]

Cureus
Khan MH, Pathan S, Ansari K, Baig S, Ghafoor A, Minhas M, Saleem K.   +6 more
europepmc   +1 more source

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019

Mayo Clinic proceedings, 2020
F. Sanchis-Gomar, C. Lavie, C. Pérez-Quilis, B. Henry, G. Lippi   +4 more
semanticscholar   +1 more source

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines

ESC Heart Failure, EarlyView.
Abstract Aims The guideline‐directed medical therapy (GDMT) sequencing strategy for patients with heart failure (HF) and reduced ejection fraction (HFrEF) underwent a paradigm shift with the 2021 ESC HF guidelines, from stepwise escalation to rapid simultaneous initiation of quadruple therapy.
Kristian Berge, Henrik Schirmer, Tarjei Øvrebotten, Hamza Nahoui, Lars Gullestad, Charlotte Björk Ingul, Torstein Hole, Rune Mo, Kristina Larsby, Tone M. Norekvål, Torbjørn Omland, Stein Ørn, Peder L. Myhre   +12 more
wiley   +1 more source